Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Request metadata listed "SOLESENCE, INC." but the filing text identifies the registrant as Nanophase Technologies Corporation).
Reporting Period: Quarterly period ended June 30, 1998 (Form 10-Q).
Business Overview: The Company develops and sells nanocrystalline materials. It transitioned from a development-stage company to full-scale commercial production in early 1997. Revenue is generated through product shipments, development arrangements, and technology licensing.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1998 | Six Months Ended June 30, 1997 |
|---|---|---|
| Total Revenue | $921,712 | $1,032,467 |
| Net Loss | $(2,486,814) | $(2,665,891) |
| Net Loss Per Share | $(0.20) | $(34.36) |
| Cash and Cash Equivalents (End of Period) | $570,209 | $2,490,130 |
| Total Investments | $28,630,202 | $26,884,852 |
| Net Cash Used in Operating Activities | $(1,431,773) | $(1,907,299) |
| Accumulated Deficit | $(16,231,485) | $(13,744,671) |
Liquidity: As of June 30, 1998, the Company held approximately $29.2 million in cash, cash equivalents, and investments. Management believes these resources are adequate to fund current operating plans.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by approximately 11% for the six months ended June 30, 1998, compared to the same period in 1997. This was primarily due to a significant reduction in "Other revenue" (development and licensing), partially offset by a 84% increase in product revenue.
- Expense Increases:
- R&D Expense: Increased to $791,022 (six months 1998) from $376,532 (six months 1997). This was driven by $425,000 in costs for new development arrangements with outside entities.
- Selling, General & Administrative (SG&A): Increased to $1,592,663 from $1,191,492. Excluding a one-time $375,103 charge in 1997 related to a withdrawn public offering, SG&A increased due to costs associated with being a public company, investor relations, and expanded sales staff.
- Interest Income: Surged to $787,866 from $31,747 due to the investment of net proceeds from the December 1997 Initial Public Offering (IPO).
- Cash Position: Cash and cash equivalents decreased by $3.4 million during the six-month period, primarily due to operating losses and net investing activities, despite high interest income.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management expects to further increase R&D and SG&A expenses for the remainder of 1998 to expand product lines and the sales force. Future capital requirements depend on customer acceptance and R&D progress; additional financing may be required and could be dilutive.
- Legal Proceedings (Material Risk): Five class-action complaints have been filed against the Company, its officers, directors, and underwriters. The complaints allege material misstatements in the IPO Registration Statement and Prospectus. Plaintiffs seek unquantified damages and rescission. The Company intends to defend vigorously but cannot predict the outcome or potential material adverse effects.
- Tax Position: The Company has a net operating loss carryforward of approximately $15.6 million and a foreign tax credit carryforward of $156,000. Utilization of the loss carryforward may be limited by ownership changes under the Internal Revenue Code.
- Year 2000 Compliance: The Company has assessed its systems and determined no significant modifications are required. It has no direct interface with significant suppliers or customers that would expose it to third-party Y2K failures.
Investor Verification Checklist
- Legal Exposure: Verify the status of the five securities class-action lawsuits filed in June and July 1998 regarding the IPO.
- Revenue Sustainability: Assess the reliance on "Other revenue" (licensing/development) which dropped significantly, versus the growth in product revenue.
- Cash Burn Rate: Monitor the rate of cash consumption given the continued net losses and the reduction in cash on hand from ~$4.0M to ~$0.6M in six months.
- R&D Spend Efficiency: Evaluate the return on the $425,000 spent on new development arrangements in Q2 1998.
- Capital Needs: Confirm if the current cash and investment portfolio ($29.2M) is sufficient to fund operations through the next 12-18 months without dilutive financing.